BSc3094 monohydrobromide, >=98% (HPLC)

Code: b7937-5mg D2-231

Not available outside of the UK & Ireland.

Application

BSc3094 is used in tau protein amyloidogenicity/tauopathy research to study the processes of tau aggregation and cross-linking in neurodegenerative disease develo...


read more

Your Price
£190.00 5MG

Not available outside of the UK & Ireland.

Application

BSc3094 is used in tau protein amyloidogenicity/tauopathy research to study the processes of tau aggregation and cross-linking in neurodegenerative disease development.

Biochem/physiol Actions

BSc3094 is a potent inhibitor of tau aggregation and dissolves preformed tau paired helical filaments. BSc3094 interacts closely with the tau protein at the edge involving protons I-IV, while the second attachment site seems to be at the nitro group. In N2A cells (model system for tau aggregation), BSc3094 exhibited low toxicity.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
formsolid
InChI keyHVNYYJJWBWMGCO-UHFFFAOYSA-N
InChI1S/C17H12N6O3S.BrH/c24-16(11-3-6-13-14(7-11)19-9-18-13)21-22-17-20-15(8-27-17)10-1-4-12(5-2-10)23(25)26;/h1-9H,(H,18,19)(H,20,22)(H,21,24);1H
Quality Level100
SMILES stringBr.[O-][N+](=O)c1ccc(cc1)-c2csc(NNC(=O)c3ccc4[nH]cnc4c3)n2
solubilityDMSO: 22 mg/mL
storage conditionprotect from light
storage temp.2-8°C
This product has met the following criteria: